Brexit FAQ: Regulation of medicinal products
13 March 2017
Industries: Life Sciences and Healthcare
Jurisdictions: United Kingdom
Life sciences companies with operations in the UK or Europe are wondering where to even start when it comes to Brexit-related legal issues. To give you a jumpstart, our colleagues from different practice groups across multiple countries have prepared a series of questions you should ask to better understand how Brexit will impact your business and to clarify what steps need to be taken. In this edition, we discuss questions related to the regulation of medicinal products.
Read the full article here